Hints and tips:
...He will be succeeded by Robert Isom, the airline’s current president. Parker will continue to serve as chair of American’s board....
...For Emma Walmsley, the chief executive of underperforming UK drugmaker GlaxoSmithKline since 2017, the pressure is on to placate her unexpected guests....
...US finance editor Robert Armstrong considers which trends are telling the real story in this video....
...However, ULA’s reliability record may be challenged by a significant looming upheaval facing its main rocket, the Atlas V....
...Aerojet said the AR1 would be ready to fly on Atlas V in 2020 and on Vulcan by 2021, only just behind the 2019 finish date that Blue Origin is targeting....
...ULA is developing a new rocket system called Vulcan to replace the Atlas V and Delta rockets and end the company’s reliance for Atlas engines on the RD-180 , built in Russia....
...Aerojet’s offer underlines the company’s desire to supply the engine for the new Vulcan rocket that ULA is developing to replace its Atlas V, which is powered by Russia-built engines that congress has said...
...The engines — powered by methane, a new propellant for US-built engines — will initially power a similar rocket to the Atlas V that ULA powers with Russian-built RD180 engines....
...The hearing had debated the timetable for developing a new, US-built alternative to the Russian RD180 rocket engine, which powers the Atlas V rocket that handles many launches of US spy and other military...
...Freemium v paid: Streaming competition swells YouTube is one of several Spotify competitors bringing streaming services to the market this year....
...David Roberts, a former Barclays executive who now sits on the Lloyds board, is seen as a second credible external candidate....
...As with Bush v Gore and Citizens United, the healthcare ruling could have a substantial impact on the direction of a US election....
...For example, its $17.4bn TPG V fund was valued at less than 100 cents on the dollar at the end of 2010....
...Allen, former United States National Security Advisor Leon Aron, American Enterprise Institute Robert Arsenault, International League for Human Rights Felice Gaer & Jacob Blaustein Institute for Human...
...It follows the UK example of British Gas, GlaxoSmithKline and Tomkins....
...In February, JPMorgan and others agreed to finance the $45bn buy-out of TXU – the largest ever announced – for Kohlberg Kravis Roberts and Texas Pacific Group, and bigger deals seemed inevitable....
...This week GlaxoSmithKline doubled the size of its share buy-back to £12bn. While the buy-out boom might have ended, corporate deals are still happening....
...A JPMorgan upgrade put life into GlaxoSmithKline....
...The year’s worst performer was Carnival, the cruise ship operator, while other notable underperformers included oil giant BPand GlaxoSmithKline, the pharmaceutical company....
...GlaxoSmithKline gained 2 per cent to £14.50 after an upgrade from Bear Stearns....
...It has outperformed the UK pharmaceuticals sector by 5.6 per cent this year and rival GlaxoSmithKline by 13.4 per cent....
...In the pharmaceuticals sector, GlaxoSmithKline improved 0.5 per cent to £13.71....
...v. Genentech, Inc. has an enormous bearing on the intellectual integrity of patent licenses. This saga starts with the famous 1969 decision in Lear v....
International Edition